TY - JOUR
T1 - Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease
AU - Austrian IBD Study Group (ATISG)
AU - Gröchenig, Hans Peter
AU - Waldhör, Thomas
AU - Haas, Thomas
AU - Wenzl, Heimo
AU - Steiner, Pius
AU - Koch, Robert
AU - Feichtenschlager, Thomas
AU - Eckhardt, Gerald
AU - Mayer, Andreas
AU - Kirchgatterer, Andreas
AU - Ludwiczek, Othmar
AU - Platzer, Reingard
AU - Papay, Pavol
AU - Gartner, Johanna
AU - Fuchssteiner, Harry
AU - Miehsler, Wolfgang
AU - Peters, Paul-Gerhard
AU - Reicht, Gerhard
AU - Kutschera, Maximilian
AU - Dejaco, Clemens
AU - Vogelsang, Harald
AU - Novacek, Gottfried
N1 - Publisher Copyright:
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - OBJECTIVE: Complementary and alternative medicine (CAM) seems to be frequently used among patients with inflammatory bowel disease (IBD). We aimed to determine the prevalence and indicators of CAM use in Austrian IBD patients.METHODS: In a multicentre cross-sectional study, adult patients with IBD attending 18 Austrian outpatient clinics completed a multi-item questionnaire that recorded use of CAM as well as medical and socioeconomic characteristics. Patients were recruited between June 2014 and June 2015. The study outcome was the prevalence of CAM use and its socioeconomic and disease-related associations.RESULTS: A total of 1286 patients (Crohn's disease 830, ulcerative colitis 435, IBD unclassified 21; females 651) with a median age of 40 years (interquartile range 31-52 years) and a median disease duration of 10 years (4-18 years) were analysed. The prevalence of previous and/or current CAM use was 50.7%, with similar results for Crohn's disease and ulcerative colitis. In the multivariable analysis, female gender and a university education were independent socioeconomic indicators of CAM use. IBD-related indicators were longer duration of the disease and previous and/or current treatment with steroids and TNF-α inhibitors.CONCLUSION: CAM use for IBD is frequent in Austrian IBD patients and associated with female gender, higher educational level of university degree, longer duration of the disease, and treatment with steroids and TNF-α inhibitors.
AB - OBJECTIVE: Complementary and alternative medicine (CAM) seems to be frequently used among patients with inflammatory bowel disease (IBD). We aimed to determine the prevalence and indicators of CAM use in Austrian IBD patients.METHODS: In a multicentre cross-sectional study, adult patients with IBD attending 18 Austrian outpatient clinics completed a multi-item questionnaire that recorded use of CAM as well as medical and socioeconomic characteristics. Patients were recruited between June 2014 and June 2015. The study outcome was the prevalence of CAM use and its socioeconomic and disease-related associations.RESULTS: A total of 1286 patients (Crohn's disease 830, ulcerative colitis 435, IBD unclassified 21; females 651) with a median age of 40 years (interquartile range 31-52 years) and a median disease duration of 10 years (4-18 years) were analysed. The prevalence of previous and/or current CAM use was 50.7%, with similar results for Crohn's disease and ulcerative colitis. In the multivariable analysis, female gender and a university education were independent socioeconomic indicators of CAM use. IBD-related indicators were longer duration of the disease and previous and/or current treatment with steroids and TNF-α inhibitors.CONCLUSION: CAM use for IBD is frequent in Austrian IBD patients and associated with female gender, higher educational level of university degree, longer duration of the disease, and treatment with steroids and TNF-α inhibitors.
KW - Adult
KW - Aged
KW - Austria
KW - Complementary Therapies/statistics & numerical data
KW - Cross-Sectional Studies
KW - Facilities and Services Utilization/statistics & numerical data
KW - Female
KW - Health Care Surveys
KW - Humans
KW - Inflammatory Bowel Diseases/therapy
KW - Male
KW - Middle Aged
KW - Patient Acceptance of Health Care/statistics & numerical data
KW - Socioeconomic Factors
UR - http://www.scopus.com/inward/record.url?scp=85071986460&partnerID=8YFLogxK
U2 - 10.1097/MEG.0000000000001533
DO - 10.1097/MEG.0000000000001533
M3 - Journal article
C2 - 31498280
SN - 0954-691X
VL - 31
SP - 1211
EP - 1219
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
IS - 10
ER -